Literature DB >> 11060498

Characterization of TRBP1 and TRBP2. Stable stem-loop structure at the 5' end of TRBP2 mRNA resembles HIV-1 TAR and is not found in its processed pseudogene.

M Duarte1, K Graham, A Daher, P L Battisti, S Bannwarth, E Segeral, K T Jeang, A Gatignol.   

Abstract

TRBP1 and TRBP2 cDNAs have been isolated based on the ability of the protein that they encode to bind HIV-1 TAR RNA. The two cDNAs have different 5' end-termini resulting in 21 additional amino acids for TRBP2 protein compared to TRBP1. The corresponding gene is conserved in mammalian species. By PCR amplification of a human library, we have isolated an additional 22 nucleotides in the 5' end of TRBP2 cDNA. Based on the addition of these 22 new nucleotides, the first 87 nucleotides of TRBP2 mRNA can fold into a stable stem-loop structure that resembles TAR RNA. We have also isolated the DNA sequence that represents the TRBP processed pseudogene. The absence of full alignment between TRBP2 full-length cDNA and this sequence suggests that the stem-loop structure could have prevented a complete reverse transcription during pseudogene formation. Using different antibodies, three forms of TRBP can be identified in primate cells at 40, 43 and 50 kD, suggesting a differential expression from the cDNAs and post-translational modifications. Both TRBP1 and TRBP2 activate the basal and the Tat-activated level of the HIV-1 LTR in human and murine cells. Our data indicate that TRBP proteins act at a level prior to Tat function. TRBP could contribute to improved HIV expression in murine models. Copyright 2000 National Science Council, ROC and S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11060498     DOI: 10.1159/000025485

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  13 in total

Review 1.  Protein interactions and complexes in human microRNA biogenesis and function.

Authors:  Marjorie P Perron; Patrick Provost
Journal:  Front Biosci       Date:  2008-01-01

2.  Dual role of TRBP in HIV replication and RNA interference: viral diversion of a cellular pathway or evasion from antiviral immunity?

Authors:  Anne Gatignol; Sébastien Lainé; Guerline Clerzius
Journal:  Retrovirology       Date:  2005-10-27       Impact factor: 4.602

Review 3.  The multiple functions of TRBP, at the hub of cell responses to viruses, stress, and cancer.

Authors:  Sylvanne M Daniels; Anne Gatignol
Journal:  Microbiol Mol Biol Rev       Date:  2012-09       Impact factor: 11.056

4.  ADAR1 interacts with PKR during human immunodeficiency virus infection of lymphocytes and contributes to viral replication.

Authors:  Guerline Clerzius; Jean-François Gélinas; Aïcha Daher; Marion Bonnet; Eliane F Meurs; Anne Gatignol
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

5.  Characterization of the TRBP domain required for dicer interaction and function in RNA interference.

Authors:  Sylvanne M Daniels; Carlos E Melendez-Peña; Robert J Scarborough; Aïcha Daher; Helen S Christensen; Mohamed El Far; Damian F J Purcell; Sébastien Lainé; Anne Gatignol
Journal:  BMC Mol Biol       Date:  2009-05-07       Impact factor: 2.946

6.  TRBP control of PACT-induced phosphorylation of protein kinase R is reversed by stress.

Authors:  Aïcha Daher; Ghislaine Laraki; Madhurima Singh; Carlos E Melendez-Peña; Sylvie Bannwarth; Antoine H F M Peters; Eliane F Meurs; Robert E Braun; Rekha C Patel; Anne Gatignol
Journal:  Mol Cell Biol       Date:  2008-10-20       Impact factor: 4.272

7.  Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production.

Authors:  Helen S Christensen; Aïcha Daher; Kaitlin J Soye; Lisa B Frankel; Marina R Alexander; Sébastien Lainé; Sylvie Bannwarth; Chi L Ong; Sean W L Chung; Shahan M Campbell; Damian F J Purcell; Anne Gatignol
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

8.  The host protein Staufen1 participates in human immunodeficiency virus type 1 assembly in live cells by influencing pr55Gag multimerization.

Authors:  Laurent Chatel-Chaix; Levon Abrahamyan; Céline Fréchina; Andrew J Mouland; Luc DesGroseillers
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

Review 9.  Protein components of the microRNA pathway and human diseases.

Authors:  Marjorie P Perron; Patrick Provost
Journal:  Methods Mol Biol       Date:  2009

Review 10.  Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome.

Authors:  Cheryl Bolinger; Kathleen Boris-Lawrie
Journal:  Retrovirology       Date:  2009-01-24       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.